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Antimicrobial susceptibility of methicillin-resistant 
Staphylococcus aureus isolates from South Africa
E Marais, N Aithma, O Perovic, W F Oosthuysen, E Musenge, A G Dusé
Staphylococcus aureus is a Gram-positive bacterium frequently 
implicated in a variety of infectious processes ranging from 
relatively benign skin infections to life-threatening systemic 
illnesses. The organism possesses several properties that 
contribute to its ability to cause serious disease, including the 
production of toxins. Since S. aureus is a significant cause of 
nosocomial and community-acquired infections, the rising rates 
of antibiotic resistance that have been noted globally are of 
concern.
Methicillin resistance in S. aureus is primarily due to 
the expression of penicillin-binding protein 2a (PBP2a/
PBP2′) which is encoded by the mecA gene of the mobile 
staphylococcal chromosomal cassette (SCCmec). Several 
SCCmec types exist that may encode resistance genes to other 
antibiotics as well. In addition to hospital-acquired methicillin-
resistant S. aureus (MRSA) (HA-MRSA), community-acquired 
MRSA (CA-MRSA) has increasingly been found to cause severe 
disease.
Information on the antibiotic susceptibility patterns of MRSA 
isolates is important for tracking the trends in antimicrobial 
resistance, for treatment approaches, and for establishing 
effective infection control measures. Baseline data from 
the Pan-European Antimicrobial Resistance Using Local 
Surveillance (PEARLS) study of 2001 - 2002 showed that 
South Africa had a MRSA prevalence of 33.3%.1 A more recent 
survey of patients with S. aureus bacteraemia at two academic 
hospitals in Johannesburg identified a MRSA rate of 23%.2 Data 
on the antibiotic susceptibility of MRSA isolates in South Africa 
are limited to a recent study of 61 isolates from KwaZulu-Natal 
(KZN)3 and from international studies performed several years 
ago.1,4
The goal of our study was to describe the antibiotic 
susceptibility profiles of MRSA isolates collected from South 
African laboratories and to correlate the results with patient 
demographic data.
Materials and methods
Participating laboratories were requested to collect non-
duplicated, consecutive MRSA isolates; these were submitted 
from 15 National Health Laboratory Services (NHLS) and 8 
private diagnostic laboratories from all 9 provinces of South 
Africa between August 2005 and November 2006. The NHLS 
is a parastatal organisation providing diagnostic laboratory 
services to public sector hospitals throughout South Africa. 
Patient demographic data comprised age and gender. 
Date of sampling and source of isolate were also collected. 
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Objective. Trends in the antibiotic susceptibility of methicillin-
resistant Staphylococcus aureus (MRSA) are regularly 
investigated in many countries, but minimal countrywide 
data are available for South Africa. The aim of this study was 
to describe the antibiotic susceptibility patterns of MRSA 
isolates collected in South Africa.
Design. Susceptibility testing of 248 MRSA isolates collected 
from 15 National Health Laboratory Services (NHLS) and 
8 private laboratories against 17 antibiotics was performed 
using the disc diffusion method. Demographic data were 
collected and correlated with antibiotic resistance patterns.
Results. Antibiotic resistance of MRSA to erythromycin, 
tetracycline, trimethoprim/sulfamethoxazole, gentamicin 
and ciprofloxacin ranged between 55% and 78%, while all 
isolates were susceptible to teicoplanin, linezolid, vancomycin 
and quinopristin/dalfopristin. A significant difference in the 
resistance pattern of the isolates towards certain antimicrobial 
agents was identified among adults and children, as well 
as between isolates collected from the private and NHLS 
laboratories.
Conclusion. This is the first extensive report on the 
antimicrobial susceptibilities of South African MRSA isolates. 
These data can assist treatment decisions and form a baseline 
for further surveillance.
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Ethics clearance was obtained from the University of the 
Witwatersrand Committee on Human Research.
S. aureus isolates were identified by standard microbiological 
methods. Genomic DNA for polymerase chain reaction 
(PCR) was isolated using a previously published ‘rapid lysis’ 
procedure.5 The mecA gene was detected using published 
primers.6 Antibiotic susceptibility was performed by the Kirby-
Bauer disc diffusion method according to CLSI guidelines:7 
15 µg erythromycin, 2 µg clindamycin, 25 µg trimethoprim/
sulfamethoxazole, 30 µg linezolid, 30 µg vancomycin, 30 µg 
teicoplanin, 30 µg chloramphenicol, 5 µg ciprofloxacin, 5 µg 
rifampicin, 10 µg gentamicin, 15 µg quinopristin/dalfopristin, 
50 µg nitrofurantoin, 30 µg amikacin, 30 µg minocycline 
and 30 µg tetracycline (Oxoid, Hampshire, England). The 
inducible MLSβ phenotype was detected using the double 
erythromycin-clindamycin disc test (D-test). Mupirocin (5 µg 
and 200 µg) and 10 µg fusidic acid testing was performed as 
described elsewhere.8,9 S. aureus strain ATCC 25923 was used 
as a control. Isolates were classified as multidrug resistant 
(MDR) if, in addition to the β-lactams, they were resistant to ≥3 
classes based on susceptibility to erythromycin, clindamycin, 
chloramphenicol, ciprofloxacin, tetracycline, trimethoprim-
sulfamethoxazole and rifampicin.10
Isolates showing intermediate resistance to teicoplanin were 
tested further using a PC20 panel on a Microscan Walkaway 
40SI (Dade Behring, CA, USA). Etest strips (AB Biodisk, Solna, 
Sweden) were used to confirm high-level mupirocin resistance 
(≥512 µg/ml) v. low-level resistance (8 - 256 µg/ml).
The data were analysed using Pearson’s chi-square test. 
Where the sample size was small, we used appropriate exact 
tests – either the binomial test (test of 2 proportions) or Fisher’s 
exact test (for contingency tables).
Results
A total of 248 non-duplicated, laboratory-confirmed 
mecA-positive MRSA isolates were available for antibiotic 
susceptibility testing – 142 isolates from NHLS laboratories 
and 106 isolates from private laboratories. Of the submitted 
samples, 236 had complete data (age, gender, date of sample 
collection and specimen source).
Demographic data reflected 101 females (42.2%) and 137 
males (57.6%); gender was not recorded for 10 patients. The 
average age was 38.7 (SD 24.0) years, 22 patients were <1 year 
old, 46 patients <18 years old, 190 patients ≥18 years old, and 
in 12 isolates the patient age was missing.
Eighty-eight (35.5%) isolates were retrieved from blood, 82 
(33.0%) from pus, 33 (13.3%) from skin wounds, 14 (5.6%) from 
the respiratory tract, and 3 (1.2%) from cerebrospinal fluid. In 
22 (8.9%) of cases, the source was not specified.
Antibiotic resistance of MRSA to erythromycin, 
trimethoprim/sulfamethoxazole, tetracycline, gentamicin 
and ciprofloxacin ranged between 55% and 78% (Table I). All 
isolates were sensitive to vancomycin, teicoplanin, linezolid, 
quinopristin/dalfopristin and fusidic acid. Although 35% of 
isolates were resistant to clindamycin by single-disc testing, the 
D-test identified erythromycin-induced clindamycin resistance 
in 68 isolates, bringing the effective total figure for clinical 
clindamycin resistance to 62.5%. Of the 9 isolates found to be 
resistant to 200 µg mupirocin by disc diffusion testing, 6 were 
confirmed to have high-level resistance (≥1 024 µg/ml) using 
Etest strips.
To assess whether antibiotic resistance phenotypes clustered 
together, antibiograms were assigned using the designation 
DECLTsRQGA (D for tetracycline, E for erythromycin, C for 
chloramphenicol, L for clindamycin, Ts for trimethoprim/
sulfamethoxazole, R for rifampicin, Q for ciprofloxacin, G for 
gentamicin, and A for amikacin). Isolates could be grouped into 
61 antibiogram patterns. Six predominant groups were found: 
ELQ (19%), E (11%), DETRG (9%), DECTQGA (7%), DTRG 
(6%) and DECLTsQGA (5%) (Table II). Of the 248 isolates, 202 
(81.5%) were found to be MDR.
The 236 isolates with patient age information were divided 
into adult (≥18 years of age) and children (<18 years of age) to 
compare resistance profiles. Resistance profiles to most of the 
antimicrobial agents were similar for adults and children, but 
significantly lower rates of resistance in children were noted for 
erythromycin (58% v. 80%, p=0.0015) and clindamycin (21% v. 
40%, p=0.018). However, resistance rates to nitrofurantion (38% 
ORIGINAL ARTICLES
Table I. Overall rates of antibiotic resistance of 248 South 
African MRSA isolates
                Number of 
                resistant isolates       %
Gentamicin       163      65.7
Amikacin        72      29.0
Erythromycin       195      78.6
Tetracycline       142      57.2
Minocycline       97      39.1
Ciprofloxacin       173      69.7
Nitrofurantoin       49      19.7
Clindamycin       87      35.0
        (68)*      (62.5)*
Trimethoprim/       137      55%
sulfamethoxazole
Chloramphenicol       48      19
Rifampicin       95      38
Mupirocin 5 µ       117      47
Mupirocin 200 µ       9      3.6
Quinupristin/dalfopristin      0      0
Vancomycin       0      0
Teicoplanin       0      0
Linezolid        0      0
Fusidic acid       0      0
Teicoplanin       0      0
Multidrug resistant       202      81.5%
Note: Intermediate resistance (CLSI criteria) was reported as resistant.
*Additional D-test positive isolates.
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v.18%, p=0.027) and gentamicin (85% v. 60%, p=0.001) were 
higher among children than adults.
The rates of antibiotic resistance in NHLS laboratories were 
compared with those from private laboratories. It was found 
that significantly more isolates were resistant to rifampicin, 
gentamicin, trimethoprim/sulfamethoxazole, chloramphenicol, 
tetracycline, minocycline and nitrofurantoin in the NHLS 
laboratories than the private laboratories, where resistance 
was higher for ciprofloxacin, clindamycin, 5 µg mupirocin and 
erythromycin (Table III).
Discussion
This study presents the first comprehensive data on antibiotic 
susceptibility patterns for MRSA in South Africa. Associations 
between resistance and private versus public systems and 
patient demographic characteristics were investigated.
The MRSA isolates were largely resistant to ciprofloxacin, 
erythromycin, gentamicin, tetracycline and trimethoprim/
sulfamethoxazole. Rates of resistance in this study were in 
some cases lower than those seen in the KZN study,3 especially 
for gentamicin (65.7% v. 97%), tetracycline (57.2% v. 90%), 
minocycline (39.1% v. 90%) and rifampicin (38 v. 74%). Only 
resistance to ciprofloxacin was notably higher in our study 
(69.7% v. 18%). These discrepancies may result from the low 
number of methicillin-resistant isolates collected for the KZN 
study. Our results correspond more closely with reports from 
northern Taiwan, in which MRSA resistance to ciprofloxacin 
and gentamicin was 65% and 73.3% respectively.11
No isolates resistant to vancomycin were detected in our 
study. Two isolates that were intermediately resistant to 
teicoplanin by disc diffusion were confirmed to be sensitive on 
the Microscan. Since the disc diffusion method is not sensitive 
for detecting intermediate resistance, additional susceptibility 
testing methods are necessary to determine the true rates of 
glycopeptide resistance in South Africa.
Eight (3%) isolates showed resistance to 200 µg mupirocin, 
a topical agent often used to eradicate nasal carriage of S. 
aureus. Of these, 6 were found to have high-level resistance to 
mupirocin by means of Etest (MIC ≥256 µg/ml). Resistance 
to high doses of mupirocin has been shown to be due to 
a plasmid-mediated mechanism, and may be of clinical 
importance. Forty-seven per cent of isolates showed resistance 
to low levels of mupirocin (using a 5 µg disc), but this may 
have limited significance as the mechanism involved may not 
be a precursor to high-level resistance.
Although 61 different antibiogram patterns were found, 
5 types made up 57% of the isolates. Previous studies 
have shown differences in antibiotic resistance profiles 
among children versus adults that are postulated to be 
due to differences in host defence during colonisation, the 
environment and antimicrobial drug selection.12 The lower 
rate of clindamycin resistance seen in our study in children, as 
opposed to adults, has been noted before.12,13 However, unlike 
these studies, the rate of gentamicin resistance in children in 
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Table II. Breakdown of the most commonly found 
antibiogram patterns of the MRSA isolates
Antibiogram  Total   %
ELQ      46  18.5
DETsRG      22  8.9
DECTsQGA     17  6.9
DTRG      15  6.0
E      14  5.6
DECLTsQGA     13  5.2
DETsRQG     11  4.4
D = tetracycline; E = erythromycin; C = chloramphenicol; L = clindamycin; Ts = 
trimethoprim/sulfamethoxazole; R = rifampicin; Q = ciprofloxacin; G = gentamicin, 
A = amikacin.
Table III. Antibiotic resistance of isolates collected in NHLS v. private laboratories
Antibiotic      NHLS laboratory (%)    Private laboratory (%)   p value
Rifampicin   52.82*    18.87      0.000
Gentamicin   85.92*    38.68      0.000
Trimethoprim/sulfamethoxazole 71.13*    33.96      0.000
Chloramphenicol   28.17*    7.55      0.000
Tetracycline   74.65*    33.96      0.000
Minocycline   49.30*    25.47      0.000
Nitrofurantoin   27.46†    14.15      0.012
Ciprofloxacin   55.63    88.68*      0.000
Clindamycin   16.90    59.43*      0.000
Mupirocin 5 µg   31.69    67.92*      0.000
Erythromycin   71.13    88.68*      0.001
Mupirocin 200 µg   2.82    4.72      NS
Amikacin    28.87    29.25      NS
Multidrug resistant   21.83    16.98      NS
*Significant at the 99% CI.
†Significant at the 95% CI.
NS = not significant.
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our study was higher than that in adults. Higher gentamicin 
resistance in children may be explained by the use of first-
generation β-lactam antibiotics such as ampicillin, which is 
recommended as an empirical treatment option for children 
with infections. It is postulated that certain types of enzymatic 
resistance to aminoglycosides are linked with the regulatory 
elements of a TEM-1 type β-lactamase gene carried by a 
transposable element.14
The differences in antimicrobial resistance patterns of isolates 
from private versus NHLS channels could be due to the 
differing pathologies of patients attending these sites and the 
treatment regimens used. Patients with pulmonary tuberculosis 
present more frequently at public hospitals and are usually 
given rifampicin as part of the standard treatment. This could 
result in the selection of resistant organisms, as reflected in 
the higher rate of resistance to this antibiotic in this sector. 
Similarly, the high rates of resistance to ciprofloxacin and 
erythromycin observed in the private sector could be related to 
the frequent use of macrolides and quinolones in this setting.
Conclusion
MRSA isolates in South Africa show high rates of resistance 
to a number of antibiotics, and most isolates are multi-
drug resistant. Our data confirm the trend of resistance 
to the macrolides, tetracycline and the aminoglycosides, 
while showing that vancomycin, teicoplanin, linezolid and 
quinopristin/dalfopristin are appropriate agents for clinical 
use. Differences in resistance profiles among adults and 
children and isolates from private versus NHLS public systems 
were found. These data may provide an empirical treatment 
guideline in clinical settings as well as a baseline for further 
antibiotic susceptibility studies.
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